Intravenous Anakinra May Be Useful in the Treatment of Cytokine Storm Syndromes
Authors of this viewpoint described the current challenges in the management of cytokine storm syndromes and reviewed the safety profile of intravenous anakinra.
All articles by Dibash Das, PhD
Significant QT Prolongation Associated With Chloroquine/Hydroxychloroquine Treatment for COVID-19
The treatment of patients with COVID-19 with chloroquine or hydroxychloroquine may result in significant QT prolongation.
Handheld Echocardiogram Adequate to Screen COVID-19-Related Cardiac Complications
Limited tablet cardiac ultrasound was found to represent an effective alternative to standard platform imaging for the screening of COVID-19-related cardiac conditions.
Hypolipidemia Associated With COVID-19, Worsens With Disease Severity
Hypolipidemia was found to be associated with COVID-19, and to worsen with disease severity.
World Scleroderma Foundation Preliminary Recommendations for Systemic Sclerosis Management During the COVID-19 Pandemic
The World Scleroderma Foundation developed preliminary guidance based on clinical questions on the SARS-CoV-2 infection for systemic sclerosis management during COVID-19.
ACR Guiding Principles for Decision-Making for In-Person vs Virtual Nonurgent Medical Care
The American College of Rheumatology developed recommendations for decision-making to distinguish between the need for in-person urgent and virtual nonurgent medical care.
COVID-19 in Italy: Ethical, Logistical and Therapeutic Dilemmas Plague Physicians
Italy’s health care system is highly regarded, having more hospital beds per capita than the United States.
Two-Drug Regimens Comparable With Three-Drug Regimens for HIV
Two-drug regimens are shown to be comparable with 3-drug regimens as viable clinical treatment options for HIV.
Transmission of DAA Resistance Inhibits Cure Rates Among HIV/HCV Coinfected MSM
The transmission of direct-acting antiviral (DAA) resistance-associated substitutions (RAS) may inhibit hepatitis C virus (HCV) cure rates and elimination efforts.
Telmisartan Adjunct Treatment May Reduce CNS Inflammation During Acute HIV
Telmisartan did not affect biomarkers of central nervous system inflammation or injury when used as an adjunct to ART for acute HIV infection.
-
Loading...
-
Loading...
Next post in CROI 2020
